Tata Chemicals Limited has informed the Exchange about Investor Presentation
November 1, 2025
The General Manager Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Scrip Code: 500770
Dear Sir / Madam,
The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: TATACHEM
Sub: Submission of Analysts/Investors Presentation
Ref: Letter dated October 24, 2025, informing about Analysts/Investors Call
With reference to the aforesaid letter, please find enclosed the presentation to be made to Analysts/ Investors on the Unaudited Consolidated and Audited Standalone financial results for the second quarter and half year ended September 30, 2025 during the Analysts/Investors call to be held on Monday, November 3, 2025.
The presentation is being submitted in compliance with Regulation 30(6) read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A copy of www.tatachemicals.com.
the presentation
is also being uploaded on
the Company's website:
You are requested to take the same on record.
Thanking you,
Yours faithfully, For Tata Chemicals Limited
Rajiv Chandan Chief General Counsel & Company Secretary
Encl.: as above
Chemistry of Sustainable Growth
Investors Communication Quarter and Half Year Ended 30 September 2025
Safe Harbour Statement
This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variations of these expressions or negatives of these terms indicating future performance or results, financial or otherwise of Tata Chemicals Limited, its direct and indirect subsidiaries and its associates. Actual results might differ substantially or materially from those expressed or implied. Important factors that could make a difference to the Company’s operations include, among others, economic conditions affecting demand / supply, price conditions in Government policies and regulations, tax laws, and other statutes and incidental factors. You are urged to view all statements contained herein with caution. Tata Chemicals Limited does not undertake any obligation to update or revise forward look statements, whether as a result of new information, future events or otherwise.
in which the Company operates, changes
in the domestic and overseas markets
Financial Highlights Quarter and Half Year Ended 30 September 2025
Performance Highlights
Q2FY26
H1FY26
Sales Volumes* (Soda Ash, Bicarb and Salt) 1,355 Kts (CQ) vs. 1,264 Kts (PQ) vs. 1,317 Kts (PY)
Sales Volumes* (Soda Ash, Bicarb and Salt) 2,620 Kts (CY) vs. 2,593 Kts (PY)
Revenue ₹ 3,877 Cr (CQ) vs. ₹ 3,719 Cr (PQ) vs. ₹ 3,999 Cr (PY)
Revenue ₹ 7,596 Cr (CY) vs. ₹ 7,788 Cr (PY)
EBITDA ₹ 537 Cr (CQ) vs. ₹ 649 Cr (PQ) vs. ₹ 618 Cr (PY)
EBITDA ₹ 1,186 Cr (CY) vs. ₹ 1,192 Cr (PY)
PAT** ₹ 219 Cr (CQ) vs. ₹ 316 Cr (PQ) vs. ₹ 267 Cr (PY)
PAT** ₹ 535 Cr (CY) vs. ₹ 442 Cr (PY)
#Net Debt (External) ₹ 5,583 Cr (Sep 25) vs. ₹ 4,884 Cr (Mar 25)
Geography
Demand
Sentiment
India
China
Asia ex. China & India
Europe
Americas
↑
↓
↑
↓
• Soda ash remains very well supplied across the world with inventories high
in certain regions.
• Soda ash prices remain weak and in certain instances nearing record low
levels.
• Global demand is estimated to be flat in near term
• Medium to long term trend is positive driven by sustainability applications
(Solar PV + EV growth), even with short term margin challenges
• Lower revenue in CQ as compared to PY, driven by lower realization due to
pricing pressure in all regions
* Lostock (UK) volumes removed ** PAT is from continuing operations, before exceptional items, after share in JV & associates and before Non-Controlling interest (‘NCI’) # Excluding Lease of ₹ 776 Cr as on Sep 25 and ₹ 768 Cr as on Mar 25 CQ – Current Quarter (Q2FY26), CY - Current Half year (H1FY26), PQ – Previous Quarter (Q1FY26) , PY – Previous Year’s Quarter (Q2FY25)/ Half Year (H1FY25)
Financial Snapshot Higher sales volumes in India, offset by lower realisation across all geographies, leading to drop in EBITDA
For the Quarter Ended 30 September 2025
Consolidated | ₹ Crore
Revenue
EBITDA
Profit Before Tax
Profit After Tax
3,877
3,719
3,999
537
649
618
301
360
348
219
316
267
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
Standalone | ₹ Crore
Revenue
1,204
1,169
1,009
EBITDA
Profit Before Tax
Profit After Tax
240
270
144
332
212
117
307
178
99
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
Q2FY26
Q1FY26
Q2FY25
PBT & PAT includes continuing operations, before exceptional items, after share in JV & associates & before NCI
Financial Snapshot Higher sales volumes in India, offset by lower realisation across all geographies, leading to drop in EBITDA
For the Half Year Ended 30 September 2025
Consolidated | ₹ Crore
Revenue
EBITDA
Profit Before Tax
Profit After Tax
7,596
7,788
1,186
1,192
661
617
535
442
H1FY26
H1FY25
H1FY26
H1FY25
H1FY26
H1FY25
H1FY26
H1FY25
Standalone | ₹ Crore
Revenue
2,373
2,056
EBITDA
Profit Before Tax
Profit After Tax
510
379
544
439
485
355
H1FY26
H1FY25
H1FY26
H1FY25
H1FY26
H1FY25
H1FY26
H1FY25
PBT & PAT includes continuing operations, before exceptional items, after share in JV & associates & before NCI
Sales and EBITDA Bridge
Sales Bridge | ₹ Crore
EBITDA Bridge | ₹ Crore
7,788
21
171
-2%
7,596
1,192
77
1,186
65
18
-1%
H1FY25
Volume & Mix
Price
H1FY26
H1FY25
Volume & Mix
* Price
Fixed Cost
H1FY26
Sales decline due to lower realization
Lower contribution offset by fixed cost control
* Price includes cost, forex and others
Unit Wise Profit & Loss
Statement of Profit and Loss for the Quarter Ended September 2025
Units
Consolidated
India
US
UK
Kenya
Rallis
₹ Crore
CQ
PQ
PY
Var vs PY
CQ
PQ
PY
Var vs PY
CQ
PQ
PY
Var vs PY
CQ
PQ
PY
Var vs PY
CQ
PQ
PY
Var vs PY
CQ
PQ
PY
Var vs PY
Revenues
EBITDA
Exceptional Items
Share of JV Income PBT1 PAT2 PAT3
3,877
3,719
3,999
(122)
1,204
1,169
1,009
537
(65)
55
301
219
77
649
618
-
42
360
316
252
-
44
348
267
194
(81)
(65)
11
(47)
(48)
(117)
240
270
144
-
-
212
178
-
-
332
307
-
-
117
99
195
96
-
-
95
79
1,282
1,208
1,391
(109)
77
188
223
(146)
-
-
(84)
(77)
-
-
30
43
-
-
78
65
-
-
(162)
(142)
396
39
(65)
-
(39)
(39)
377
32
-
-
(31)
(31)
531
(135)
26
-
-
(59)
(59)
13
(65)
-
20
20
129
18
-
-
17
(2)
134
17
-
-
19
18
168
43
-
-
47
40
(39)
(25)
-
-
(30)
(42)
860
157
957
150
-
-
-
-
137
102
129
95
928
166
-
-
143
99
(68)
(9)
-
-
(6)
3
Statement of Profit and Loss for the Half Year Ended September 2025
Units
₹ Crore
Revenues
EBITDA
Exceptional Items
Share of JV Income
PBT1
PAT2
PAT3
Consolidated
India
CY
PY
Var
CY
PY
Var
CY
US
PY
Var
CY
UK
PY
Kenya
Rallis
Var
CY
PY
Var
CY
PY
Var
7,596
1,186
7,788
1,192
(65)
97
661
535
329
-
98
617
442
329
(192)
2,373
2,056
510
379
-
-
544
485
-
-
439
355
(6)
(65)
(1)
44
93
-
317
131
-
-
105
130
2,490
2,672
264
421
-
-
(54)
(34)
-
-
124
103
(182)
(157)
-
-
(178)
(137)
774
72
(65)
-
(70)
(70)
1,056
(282)
43
-
-
(119)
(119)
29
(65)
-
49
49
263
35
-
-
36
16
317
68
-
-
81
73
(54)
(33)
-
-
(45)
(57)
1,818
1,711
306
262
-
-
266
197
-
-
208
147
107
44
-
-
58
50
Notes : Above financials are for Continuing Operations Consolidated financials is after adjusting SPV & other adjustments Rallis’ financials represent 100% share. Consolidated numbers is after adjustment of Rallis India’s NCI.
1. Before exceptional items and after JV share 2. Before exceptional items and NCI 3. After exceptional items and NCI
Balance Sheet
Non - Current Assets
Inventories
Investments
Trade Receivables
Cash and Bank Balance
Others Current Assets
Total Assets
Equity & Reserves
Non - Controlling Interests
Non-Current Liabilities
Borrowings (Non-Current)/ Lease Liabilities
Borrowings (Current)/ Lease Liabilities
Trade Payables
Others Current Liabilities
Total Liabilities
Particulars
Consolidated (₹ Cr)
Standalone (₹ Cr)
30-Sep-25
32,200
31-Mar-25
31,060
30-Sep-25
21,262
31-Mar-25
20,778
2,626
674
2,060
462
833
38,855
22,358
973
4,594
6,044
1,451
2,184
1,251
2,558
805
1,900
615
842
37,780
21,594
907
4,324
4,816
2,256
2,510
1,373
859
245
206
47
215
22,834
18,830
-
1,159
1,975
35
508
327
947
397
252
71
266
22,711
18,194
-
1,056
1,777
484
777
423
38,855
37,780
22,834
22,711
Sales Volume Key Products
India
849
58
802
62
US
868
77
Kenya
1,651
1,692
120
146
India
UK
62
15
56
12
52
118
104
27
19
39
India
UK
444
73
407
397
72
75
851
145
797
150
599
542
632
1,141
1,220
192
198
159
390
326
47
44
91
33
65
371
335
322
706
647
Q2FY26
Q1FY26
Q2FY25
H1FY26
H1FY25
Q2FY26 Q1FY26 Q2FY25 H1FY26 H1FY25
Q2FY26 Q1FY26 Q2FY25 H1FY26 H1FY25
* Lostock (UK) volumes removed
Historical Financial Trends
3,730
3,475
3,789
3,999
3,590
3,509
3,719
3,877
1,093
1,090
1,047
1,009
1,166
1,219
1,169
1,204
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
700
600
500
400
300
200
100
-
1,000
800
600
400
200
-
(200)
542
15%
443
13%
574
618
15%
15%
649
17%
537
14%
434
12%
327
9%
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
5%
194
4%
145
5%
175
7%
267
1%
49
0% (12)
8%
316
6%
219
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
30%
25%
20%
15%
10%
5%
0%
25%
20%
15%
10%
5%
0%
-5%
1,000
900
800
700
600
500
400
300
200
100
-
1,000
900
800
700
600
500
400
300
200
100
-
19%
18%
22%
206
192
235
14%
144
18%
19%
23%
20%
209
230
270
240
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
24%
20%
217
256
11%
115
10%
99
6%
72
8%
97
26%
307
15%
178
Q3FY24
Q4FY24
Q1FY25
Q2FY25
Q3FY25
Q4FY25
Q1FY26
Q2FY26
40%
35%
30%
25%
20%
15%
10%
5%
0%
40%
35%
30%
25%
20%
15%
10%
5%
0%
Note: PAT is after share of JV and before exceptional items & NCI
Strategic Priorities Paving the Path Forward
Operational and functional performance through • Innovation • Digitalization • People
Sustainability aligned to ESG framework • Project Aalingana
Leadership through growing core and broadening the specialty portfolio • Revenue maximization • Realization of new capacities • Optimizing product portfolio
Excel
Embed
Expand
ESG Focus Sustainable & Ethical Impacts
Climate Change Absolute carbon emission reduction
Circular Economy Water Neutrality, zero solid waste and recycle
Bio-diversity Preserve Natural Capital, conservation & restoration of biodiversity
Focus Areas & Projects
• ESG Rating maintained at “Adequate” by CRISIL
• Biogenic fuel (biomass) trials progressing in India
• 5 MW Solar plant and Electric Calciner
commissioned in Magadi
• Cumulative capacity of 801.95 million cubic feet
(MCFT) of water harvesting capacity created
• Total whale sharks which have been rescued and
released are 986 since start of the project
• 1 MW solar at Mithapur commissioned
• Applications for DJSI and CDP submitted
• 2
seasons
completed
for
Biodiversity
Assessment at Mithapur
Annexure Tata Chemicals Background
Our Facilities - Footprint Across 4 Continents India Operations - 11 Manufacturing Units
Installed Capacity Soda Ash: 1,091,000 MTPA Bicarb: 290,000 MTPA Salt: 1,600,000 MTPA Cement: 5,00,000 MTPA
Location Gujarat
Installed Capacity Prebiotic: 5,000 MTPA Specialty Silica:10,800 MTPA
Major Products Crop Care, Crop Protection and Seeds (Herbicides, Fungicides and Insecticides etc.)
Location Andhra Pradesh and Tamil Nadu
Location Maharashtra, Gujarat and Hyderabad
1 Tata Chem India holds 55.04% stake in Rallis India Limited
Our Facilities - Footprint Across 4 Continents International Operations - 4 Manufacturing Units
Installed Capacity Soda Ash: 2,540,000 MTPA
Installed Capacity Bicarb: 90,000 MTPA Salt: 430,000 MTPA Pharma Salt : 70,000 MTPA
Installed Capacity Soda Ash: 350,000 MTPA
Location Wyoming, USA
Location Winnington and Middlewich, UK
Location Magadi, Kenya
Our Facilities R&D Centers
Tata Chem India Innovation Centre
Rallis India R&D Centre
200+ Technically Skilled
Scientists in R&D 3 State-of-the-art
Innovation Centers 451 Patents Filed
176 Granted
Thank You
For any queries, please contact below :
Vijay Furia vfuria@tatachemicals.com
Damini Jhunjhunwala djhunjhunwala@tatachemicals.com